Metabolism of borono-phenylalanine–fructose complex (BPA–fr) and borocaptate sodium (BSH) in cancer patients—Results from EORTC trial 11001
Authors:
- Peter BendelPBPeter Bendel
- Andrea WittigAWAndrea Wittig
- Fabrizio BasilicoFBFabrizio Basilico
- Pier Luigi MauriPier Luigi Mauri
- Wolfgang SauerweinWSWolfgang Sauerwein
- 1 January 2010
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 51 (1) , 284-287
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Early clinical trial concept for boron neutron capture therapy: A critical assessment of the EORTC trial 11001Applied Radiation and Isotopes, 2009
- Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT)Critical Reviews in Oncology/Hematology, 2008
- Boron neutron capture therapy for glioblastomaCancer Letters, 2008
- Uptake of two 10B‐compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001)International Journal of Cancer, 2007
- Stability of 10B-l-boronophenylalanine–fructose injectionAmerican Journal of Health-System Pharmacy, 2005
- Noninvasive QuantitativeIn VivoMapping and Metabolism of Boronophenylalanine (BPA) by Nuclear Magnetic Resonance (NMR) Spectroscopy and ImagingRadiation Research, 2005
- Boron Neutron Capture Therapy of Cancer: Current Status and Future ProspectsClinical Cancer Research, 2005
- Biomedical applications of 10B and 11B NMRNMR in Biomedicine, 2005
- Significant differences in the retention of the borocaptate monomer (BSH) and dimer (BSSB) in malignant cellsCancer Letters, 2001
- Uptake and Washout of Borocaptate Sodium and Borono-phenylalanine in Cultured Melanoma Cells: A Multi-nuclear NMR StudyRadiation Research, 2000